ArticleBMC cancer2021

Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters.

Guohua Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.